FTSE 100 Poised to Extend Gains Despite AstraZeneca Vaccine Concerns

The UK benchmark FTSE 100 may shrug aside concerns regarding the AstraZeneca coronavirus vaccine and push to fresh post-crisis highs, on the back of swelling optimism as Britain progresses to the n…

Related Articles

Responses

Your email address will not be published. Required fields are marked *